Differential regulation of GAD67, enkephalin and dynorphin mRNAs by chronic-intermittent L-dopa and A2A receptor blockade plus L-dopa in dopamine-denervated rats

Synapse

Volumn 44, Issue 3, 2002, Pages 166-174

  Carta, Anna R ^a   Pinna, Annalisa ^a   Cauli, Omar ^a   Morelli, Micaela ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Adenosine; Dyskinesia; In situ hybridization; Parkinson's disease; Striatum

Indexed keywords

5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR ANTAGONIST; BENSERAZIDE; DOPAMINE; DYNORPHIN; ENKEPHALIN; GLUTAMATE DECARBOXYLASE; LEVODOPA; MESSENGER RNA; OXIDOPAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTONOMIC DENERVATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DOPAMINERGIC SYSTEM; DRUG EFFECT; DYSKINESIA; EFFERENT NERVE; IN SITU HYBRIDIZATION; LONG TERM EXPOSURE; NERVE CONDUCTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

ANIMALS; CORPUS STRIATUM; DENERVATION; DOPAMINE; DOPAMINE AGENTS; DYNORPHINS; ENKEPHALINS; GLUTAMATE DECARBOXYLASE; ISOENZYMES; LEVODOPA; MALE; NEUROPROTECTIVE AGENTS; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A2A; RECEPTORS, PURINERGIC P1; RNA, MESSENGER; TRIAZOLES;

EID: 0037013695     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.10066     Document Type: Article

References (53)

1. 2A, receptors in the nucleus accumbens mediate locomotor depression
2. L-dopa-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin-and glutamic acid decarboxylase mRNA
3. 2 receptor knockout mice
4. Increased striatal expression of glutamate decarboxylase 67 after priming of 6-hydroxydopamine-lesioned rats
5. 2 receptors in stably cotransfected cells
6. Primate models of movement disorders of basal ganglia origin
7. 2 receptor involvement in the hypomobility effects of adenosine analogues in mice
8. Enhancement of the behavioral response to apomorphin following repeated treatment in the 6-hydroxydopamine-lesioned rat is temporally correlated with a rise in pre-proenkephalin B, but not pre-proenkephalin A, gene expression
9. Levodopa replacement therapy alters enzyme activities in striatum and neuropeptide content in striatal output regions of 6-hydroxydopamine lesioned rats
10. 2A receptor antagonism potentiates L-dopa-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats
11. Stimulation of high affinity adenosine A-2 receptors decreases the affinity of dopamine D-2 receptors in rat striatal membranes
12. Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia
13. 2 dopamine receptors in rat striatum
14. The neostriatal mosaic: Multiple levels of compartmental organization
15. 2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons
16. Comparison of the behavioral effects of an adenosine A1/A2-receptor antagonist, CGS 5943A, and an Al-selective antagonist, DPCPX
17. 2A receptor antagonist in MPTP-treated monkeys
18. Stimulation of adenosine A2a receptors in the rat striatum induces catalepsy that is reversed by antagonists of N-methyl-D-aspartate receptors
19. Characterization of enhanced behavioral responses to L-dopa following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease
20. Effects of L-dopa on preproenkephalin and preprotachykinin gene expression in the MPTP-treated monkey striatum
21. Adenosine receptor antagonists potentiate dopamine receptor agonist-induced rotational behavior in 6-hydroxydopamine-lesioned rats
22. Combined use of the adenosine A(2A) antagonist KW-6002 with L-dopa or with selective D1 or D2 dopamine agonists increases antiparkinsonian activity but not dyskinesia in MPTP-treated monkeys
23. Projection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin
24. Dopamine receptor gene expression by enkephalin neurons in rat forebrain
25. 1 receptor-mediated effects on c-fos expression
26. Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies
27. Effects of nigrostriatal denervation and L-Dopa therapy on the GABAergic neurons of the striatum in MPTP-treated monkeys and Parkinson's disease: An in situ hybridization study of GAD67 mRNA
28. Dopaminergic regulation of glutamic acid decarboxylase mRNA expression and GABA release in the striatum: A review
29. 2 receptors in unilaterally 6-hydroxydopamine-lesioned rats
30. 2 receptors stimulate c-fos expression in striatal neurons of 6-hydroxydopamine-lesioned rats
31. 2 receptor agonists
32. 2A receptors
33. Motor fluctuations in levodopa treated parkinsonian rats: Relation to lesion extent and treatment duration
34. Immunocytochemical localization of enkephalin in the neostriatum of rat brain: A light and electron microscopic study
35. 1 agonists in dopamine-denervated rats
36. 2A receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6-hydroxydopamine-lesioned rats
37. 1 dopamine agonist on rotational behavior and striatal c-Fos induction in 6-hydroxydopamine-lesioned rats
38. 2A receptor antagonists as new agents for the treatment of Parkinson's disease
39. Differential regional effects of long-term L-dopa treatment on preproenkephalin and preprotachykinin gene expression in the striatum of 6-hydroxydopamine-lesioned rat
40. The striatal restricted adenosine A2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons. An in situ hybridization histochemistry study
41. Messenger RNAs encoding glutamate-decarboxylases are differentially affected by nigrostriatal lesions in subpopulations of striatal neurons
42. L-dopa regulates glutamate decarboxylase mRNA levels in MPTP-treated monkeys
43. Glutamate decarboxylase (GAD67 and GAD65) gene expression is increased in a subpopulation of neurons in the putamen of parkinsonian monkeys
44. 2A receptor messenger RNA in the rat central nervous system with special reference to dopamine innervated areas
45. Similar time course changes in striatal levels of glutamic acid decarboxylase and proenkephalin mRNA following dopaminergic deafferentation in the rat
46. Immunohistochemical evidence for a dynorphin immunoreactive striatonigral pathway
47. Increase of enkephalin and decrease of substance P immunoreactivity in the dorsal and ventral striatum of the rat after midbrain 6-hydroxydopamine lesions
48. Chronic L-dopa treatment differentially regulates gene expression cf glutamate decarboxylase, preproenkephalin and preprotachykinin in the striatum of 6-hydroxydopamine-lesioned rat
49. Alterations in preproenkephalin and adenosine-2a receptor mRNA, but not preprotachykinin mRNA correlate with occurrence of dyskinesia in normal monkeys chronically treated with L-dopa